Tissue factor pathway inhibitor (TFPI) and its response to heparin in patients with spontaneous deep vein thrombosis.
Holst
J
J
Department of Surgery, Lund University, Malmö General Hospital, Sweden.
Lindblad
B
B
Wedeberg
E
E
Bergqvist
D
D
Nordfang
O
O
Ostergaard
P B
PB
Hedner
U
U
D000368:Aged; D000990:Antithrombin III / Q000378:metabolism; D065427:Factor Xa Inhibitors; D005260:Female; D006493:Heparin / Q000627:therapeutic use*; D006801:Humans; D008074:Lipoproteins / Q000097:blood*; D008297:Male; D008875:Middle Aged; D010314:Partial Thromboplastin Time; D011516:Prothrombin / Q000037:antagonists & inhibitors; D015842:Serine Proteinase Inhibitors / Q000097:blood*; D013924:Thrombophlebitis / Q000097:blood* / Q000188:drug therapy*
D065427:Factor Xa Inhibitors; D008074:Lipoproteins; D015842:Serine Proteinase Inhibitors; C051928:lipoprotein-associated coagulation inhibitor; D000990:Antithrombin III; D011516:Prothrombin; C025337:Factor IIa; D006493:Heparin